142 related articles for article (PubMed ID: 24212987)
21. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
22. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
23. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
24. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
25. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.
Geomela PA; Kontos CK; Yiotakis I; Fragoulis EG; Scorilas A
BMC Cancer; 2012 Oct; 12():484. PubMed ID: 23083099
[TBL] [Abstract][Full Text] [Related]
26. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
27. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
28. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
29. DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors.
Lima LM; de Souza LR; da Silva TF; Pereira CS; Guimarães AL; de Paula AM; de Andrade Carvalho H
Histopathology; 2012 Feb; 60(3):489-96. PubMed ID: 22176134
[TBL] [Abstract][Full Text] [Related]
30. Telomeric Repeat-Containing RNAs (TERRA) Decrease in Squamous Cell Carcinoma of the Head and Neck Is Associated with Worsened Clinical Outcome.
Vitelli V; Falvo P; G Nergadze S; Santagostino M; Khoriauli L; Pellanda P; Bertino G; Occhini A; Benazzo M; Morbini P; Paulli M; Porta C; Giulotto E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342094
[TBL] [Abstract][Full Text] [Related]
31. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
Takikita M; Xie R; Chung JY; Cho H; Ylaya K; Hong SM; Moskaluk CA; Hewitt SM
J Transl Med; 2011 Jul; 9():126. PubMed ID: 21801427
[TBL] [Abstract][Full Text] [Related]
32. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma.
Feng Z; Li JN; Wang L; Pu YF; Wang Y; Guo CB
Histopathology; 2014 Feb; 64(3):348-55. PubMed ID: 24274692
[TBL] [Abstract][Full Text] [Related]
34. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
Ganci F; Sacconi A; Bossel Ben-Moshe N; Manciocco V; Sperduti I; Strigari L; Covello R; Benevolo M; Pescarmona E; Domany E; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
Ann Oncol; 2013 Dec; 24(12):3082-8. PubMed ID: 24107801
[TBL] [Abstract][Full Text] [Related]
35. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
37. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
Mahjabeen I; Ali K; Zhou X; Kayani MA
Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
[TBL] [Abstract][Full Text] [Related]
39. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.
Miller ME; Palla B; Chen Q; Elashoff DA; Abemayor E; St John MA; Lai CK
Am J Otolaryngol; 2012; 33(2):212-5. PubMed ID: 22177613
[TBL] [Abstract][Full Text] [Related]
40. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]